Secondary immunodeficiency in lymphoproliferative malignancies

V Friman, O Winqvist, C Blimark… - Hematological …, 2016 - Wiley Online Library
Secondary immunodeficiencies occur as a consequence of various diseases, including
hematological malignancies, and the use of pharmacological therapies, such as …

Secondary immunodeficiency in lymphoproliferative malignancies

V Friman, O Winqvist, C Blimark… - Hematological …, 2016 - pubmed.ncbi.nlm.nih.gov
Secondary immunodeficiencies occur as a consequence of various diseases, including
hematological malignancies, and the use of pharmacological therapies, such as …

Secondary immunodeficiency in lymphoproliferative malignancies

V Friman, O Winqvist, C Blimark, P Langerbeins… - Hematological …, 2016 - infona.pl
Secondary immunodeficiencies occur as a consequence of various diseases, including
hematological malignancies, and the use of pharmacological therapies, such as …

Secondary immunodeficiency in lymphoproliferative malignancies.

V Friman, O Winqvist, C Blimark… - Hematological …, 2016 - europepmc.org
Secondary immunodeficiencies occur as a consequence of various diseases, including
hematological malignancies, and the use of pharmacological therapies, such as …

Secondary immunodeficiency in lymphoproliferative malignancies

V Friman, O Winqvist, C Blimark… - Hematol …, 2016 - kups.ub.uni-koeln.de
Secondary immunodeficiencies occur as a consequence of various diseases, including
hematological malignancies, and the use of pharmacological therapies, such as …

Secondary immunodeficiency in lymphoproliferative malignancies.

V Friman, O Winqvist, C Blimark… - Hematological …, 2016 - ora.ox.ac.uk
Secondary immunodeficiencies occur as a consequence of various diseases, including
hematological malignancies, and the use of pharmacological therapies, such as …

Secondary immunodeficiency in lymphoproliferative malignancies

V Friman, O Winqvist, C Blimark… - Hematol …, 2016 - kups.ub.uni-koeln.de
Secondary immunodeficiencies occur as a consequence of various diseases, including
hematological malignancies, and the use of pharmacological therapies, such as …